Weiguo Ye's most recent trade in Gyre Therapeutics Inc was a trade of 2,800 Common Stock done at an average price of $0.8 . Disclosure was reported to the exchange on June 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.75 per share. | 11 Jun 2026 | 2,800 | 702,800 | - | 0.8 | 2,100 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2026 | 2,800 | 838,701 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.17 per share. | 11 Jun 2026 | 2,800 | 700,000 | - | 6.2 | 17,276 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.75 per share. | 09 Jun 2026 | 14,500 | 714,500 | - | 0.8 | 10,875 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2026 | 14,500 | 847,919 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.14 per share. | 09 Jun 2026 | 14,500 | 700,000 | - | 6.1 | 89,030 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2026 | 6,418 | 841,501 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.21 per share. | 09 Jun 2026 | 6,418 | 700,000 | - | 6.2 | 39,856 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.75 per share. | 09 Jun 2026 | 6,418 | 706,418 | - | 0.8 | 4,814 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.24 per share. | 09 Jun 2026 | 5,000 | 700,000 | - | 6.2 | 31,200 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.75 per share. | 09 Jun 2026 | 5,000 | 705,000 | - | 0.8 | 3,750 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2026 | 5,000 | 830,701 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2026 | 3,000 | 835,701 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.35 per share. | 09 Jun 2026 | 3,000 | 700,000 | - | 6.4 | 19,050 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.75 per share. | 09 Jun 2026 | 3,000 | 703,000 | - | 0.8 | 2,250 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.15 per share. | 09 Jun 2026 | 3,000 | 700,000 | - | 6.2 | 18,450 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.75 per share. | 09 Jun 2026 | 3,000 | 703,000 | - | 0.8 | 2,250 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jun 2026 | 3,000 | 827,701 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.75 per share. | 04 Jun 2026 | 19,575 | 719,575 | - | 0.7 | 14,681 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2026 | 19,575 | 877,820 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.13 per share. | 04 Jun 2026 | 19,575 | 700,000 | - | 6.1 | 119,995 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2026 | 15,401 | 862,419 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.40 per share. | 04 Jun 2026 | 15,401 | 700,000 | - | 6.4 | 98,566 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.75 per share. | 04 Jun 2026 | 15,401 | 715,401 | - | 0.8 | 11,551 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2026 | 4,000 | 897,395 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.10 per share. | 22 May 2026 | 4,000 | 700,000 | - | 6.1 | 24,400 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.75 per share. | 22 May 2026 | 4,000 | 704,000 | - | 0.8 | 3,000 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.75 per share. | 22 May 2026 | 3,500 | 703,500 | - | 0.8 | 2,625 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2026 | 3,500 | 901,395 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.08 per share. | 22 May 2026 | 3,500 | 700,000 | - | 6.1 | 21,280 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2026 | 12,820 | 904,895 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.75 per share. | 20 May 2026 | 12,820 | 712,820 | - | 0.8 | 9,615 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.15 per share. | 20 May 2026 | 12,820 | 700,000 | - | 6.2 | 78,843 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.75 per share. | 20 May 2026 | 9,400 | 709,400 | - | 0.8 | 7,050 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.15 per share. | 20 May 2026 | 9,400 | 700,000 | - | 6.2 | 57,810 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2026 | 9,400 | 917,715 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2026 | 9,120 | 927,115 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.37 per share. | 18 May 2026 | 9,120 | 700,000 | - | 6.4 | 58,094 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.75 per share. | 18 May 2026 | 9,120 | 709,120 | - | 0.8 | 6,840 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.75 per share. | 18 May 2026 | 200 | 700,200 | - | 0.8 | 150 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2026 | 200 | 936,235 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.62 per share. | 18 May 2026 | 200 | 700,000 | - | 6.6 | 1,324 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.75 per share. | 14 May 2026 | 15,580 | 715,580 | - | 0.8 | 11,685 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2026 | 15,580 | 949,535 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.91 per share. | 14 May 2026 | 15,580 | 700,000 | - | 6.9 | 107,658 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2026 | 13,100 | 936,435 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 6.65 per share. | 14 May 2026 | 13,100 | 700,000 | - | 6.7 | 87,115 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.75 per share. | 14 May 2026 | 13,100 | 713,100 | - | 0.8 | 9,825 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.75 per share. | 01 Apr 2025 | 50,000 | 700,000 | - | 0.8 | 37,500 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 50,000 | 965,115 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2025 | 300,000 | 1,365,115 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.75 per share. | 24 Mar 2025 | 300,000 | 300,000 | - | 0.8 | 225,000 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2025 | 200,000 | 1,165,115 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.75 per share. | 24 Mar 2025 | 200,000 | 500,000 | - | 0.8 | 150,000 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.75 per share. | 24 Mar 2025 | 150,000 | 650,000 | - | 0.8 | 112,500 | Common Stock |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2025 | 150,000 | 1,015,115 | - | - | Stock Option (Right to Buy) | |
| Gyre Therapeutics Inc | Weiguo Ye | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) |